Warning letter
Cooley Dickinson Hospital, BB [ARCHIVED]: warning letter of Aug 26, 2009
FDA warning letter 72083 · New England District Office
Key facts
| Reference number | 72083 |
|---|---|
| Company | Cooley Dickinson Hospital, BB [ARCHIVED] |
| Subject | CGMP for Finished Pharmaceuticals/Adulterated |
| Issue date | Aug 26, 2009 |
| Posted date | Aug 26, 2009 |
| Issuing office | New England District Office |
| Product type | Biologics |
| CFR sections cited | 211, 211.68, 610.41, 606.100(b), 606.160(b), 610.40(h) |
| Inspection city | Northampton |
| Inspection ZIP | 01060 |
| Inspection start date | Jul 6, 2009 |
| Letter on fda.gov | web.archive.org |
At a glance
- 1–9 CFR sections cited
- OAI Linked inspection classification
- Yes Form FDA 483 issued
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About FDA warning letters
FDA warning letters notify a firm of significant regulatory violations found during an inspection or review and request prompt corrective action.
Source: U.S. Food and Drug Administration (FDA), Warning Letters · Source date: